Cornerstone Therapeutics (CRTX -11.5%) plummets after saying it has received a letter from Exela...

|About: Cornerstone Therapeutics Inc. (CRTX)|By:, SA News Editor

Cornerstone Therapeutics (CRTX -11.5%) plummets after saying it has received a letter from Exela Pharma regarding the filing of an NDA for a product similar to CRTX's CARDENE I.V. Premixed Injection. The company says it will "pursue all available legal and regulatory avenues in defense" of CARDENE. (PR)